Patients Patients not just at the table, but creating their own: In c... Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.
Patients Healthcare wants patients at the centre. So, why are they st... Claire Gillis reflects on a surprising controversy at ESMO 2026, and the uncomfortable questions it raises for healthcare.
Patients Why “rare disease” is a regulatory label, not a patient real... Regulators define a rare disease by how many people have it, and the answer depends on who is counting.
Patients Patient engagement drives clinical and commercial success Engagement solutions can tap into long-lasting patient motivations that sustain behaviour.
Patients Sponsored 7 Strategies for fixing pharma's outdated patient engagement... The term 'patient centricity' has undergone a radical evolution over recent years.
Patients 2025: The year of the patient? Across the clinical trials industry last year, there was much greater appetite for listening to patient insights and considering the patient perspective.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.